NCT01213160View on ClinicalTrials.gov

Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

CancerAdvanced Solid Malignancies

Interventions

DRUG

AZD4547

film coated tablet, PO, twice daily

Trial Locations (3)

Unknown

Research Site, Chūōku

Research Site, Nagoya

Research Site, Sapporo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY